EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Association Between Sensorineural Hearing Loss and Neurocognitive Performance in Survivors of Childhood Cancer: A Systematic Review and Meta‐Analysis

Jennifer E Schlak iD, Tripti Shukla iD, Anne Eaton iD, Lindsay Blake iD, Alicia Kunin-Batson iD, Ellen van der Plas iD

Cancer Medicine · 2025

DOI: 10.1002/cam4.71394 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancer Medicine, 2025. Verfasst von Jennifer E Schlak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Behavioral Neuroscience, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Cancer Survivors, Hearing Loss, Sensorineural, Neoplasms, Neurocognitive Disorders. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Arkansas Children's Research Institute, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Various studies have shown that sensorineural hearing loss (SNHL) is associated with neurocognitive impairment among childhood cancer survivors, though prior studies are limited by small sample sizes and inconsistent methods.

Objective

This systematic review and meta‐analysis aimed to quantify neurocognitive differences between survivors with severe SNHL (s‐SNHL) and those without.

Methods

Studies were included if they evaluated childhood cancer survivors (diagnosed ≤ 21 years), were ≥ 2 years posttreatment, received cranial radiation and/or platinum‐based chemotherapy, used validated neurocognitive tests, and included survivors with and without SNHL. Methods and reporting adhered to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines. Databases searched included PubMed, Web of Science, Cochrane, Scopus, PsycINFO, and Embase. Study quality was assessed using an adapted version of the Newcastle–Ottawa Scale. We collected study details, including authors, year, neurocognitive tests used, sample sizes, and group scores (means and standard deviations [SD]). Pooled mean differences (MD) and 95% confidence intervals (95% CI) were calculated using standard scores (mean = 100, SD = 15) and random‐effects models.

Results

Of 1012 records identified, nine studies were included in the analyses, with 503 childhood cancer survivors with s‐SNHL and 1553 survivors without s‐SNHL. Compared to survivors without s‐SNHL, survivors with s‐SNHL scored lower on measures of overall intellectual functioning (MD = −8.1, 95% CI = −10.0, −6.2), verbal reasoning (MD = −9.7, 95% CI = −11.4, −7.9), perceptual reasoning (MD = −6.6, 95% CI = −11.1, −2.1), working memory (MD = −5.3, 95% CI = −7.1, −3.4), processing speed (MD = −6.3, 95% CI = −9.9, −2.6), short‐term visual memory (MD = −6.0, 95% CI = −8.2, −3.7), and reading (MD = −6.2, 95% CI = −7.9, −4.5).

Conclusions

Severe SNHL is associated with significant neurocognitive deficits in childhood cancer survivors. Routine hearing screening and timely neurocognitive assessments are recommended to identify and address these impairments. Trial Registration PROSPERO: CRD42023440952

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsHearing Loss, SensorineuralNeoplasmsNeurocognitive DisordersHumansChildNeuropsychological Tests

Stichwörter der Autor:innen

childhood cancer survivorsneurocognitive performanceneuropsychological testsplatinum‐based chemotherapyradiationsensorineural hearing loss

Autor:innen und Institutionen

  • Clinical Behavioral Neuroscience, University of Minnesota, Minneapolis, Minnesota, USA.
  • University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Division of Biostatistics & Health Data Science, University of Minnesota, Minneapolis, Minnesota, USA.
  • Division of Research and Evidence-Based Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Division of Hematology/Oncology, Arkansas Children's Hospital, Little Rock, Arkansas, USA.

ORCID-Profile: Jennifer E Schlak, Tripti Shukla, Anne Eaton, Lindsay Blake, Alicia Kunin-Batson, Ellen van der Plas

Förderung

  • NCI NIH HHS
  • Arkansas Children's Research Institute
  • NIH HHS
  • UAMS Winthrop P. Rockefeller Cancer Institute
  • National Institutes of Health

Zitieren

APA

Schlak, J. E., Shukla, T., Eaton, A., Blake, L., Kunin-Batson, A., & van der Plas, E. (2025). Association Between Sensorineural Hearing Loss and Neurocognitive Performance in Survivors of Childhood Cancer: A Systematic Review and Meta‐Analysis. Cancer Medicine. https://doi.org/10.1002/cam4.71394

Vancouver

Schlak JE, Shukla T, Eaton A, Blake L, Kunin-Batson A, van der Plas E. Association Between Sensorineural Hearing Loss and Neurocognitive Performance in Survivors of Childhood Cancer: A Systematic Review and Meta‐Analysis. Cancer Medicine. 2025. doi:10.1002/cam4.71394

BibTeX
@article{Schlak2025,
  author = {Schlak, Jennifer E and Shukla, Tripti and Eaton, Anne and Blake, Lindsay and Kunin-Batson, Alicia and van der Plas, Ellen},
  title = {Association Between Sensorineural Hearing Loss and Neurocognitive Performance in Survivors of Childhood Cancer: A Systematic Review and Meta‐Analysis},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71394}
}
Kostenlos starten →